Standard BioTools Inc. (LAB) stock declined over -0.40%, trading at $1.88 on NASDAQ, down from the previous close of $1.89. The stock opened at $1.87, fluctuating between $1.86 and $1.90 in the recent session.
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, Advanta Dx SARS-CoV-2 RT-PCR assays, Advanta Dx COVID-19 EASE assays, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 systems; preparatory analytical instruments, which include C1 IFCs; and software solutions. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. Standard BioTools Inc. has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.
Employees | 534 |
Beta | 1.582 |
Sales or Revenue | $106.34M |
5Y Sales Change% | -0.528% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Diagnostics & Research |
Standard BioTools Inc. (NASDAQ: LAB) stock price is $1.88 in the last trading session. During the trading session, LAB stock reached the peak price of $1.90 while $1.86 was the lowest point it dropped to. The percentage change in LAB stock occurred in the recent session was -0.4% while the dollar amount for the price change in LAB stock was -$0.01.
The NASDAQ listed LAB is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. Standard BioTools Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Jeremy Steven Davis
Chief Commercial Officer
Dr. Stephen R. Quake D.phil., Ph.D.
Co-Founder & Chairman of Advisory Board
Mr. Andrew Quong Ph.D.
Chief Science Officer
Mark Spearman
Senior Director of Corporation Communications
Mr. Jeffrey G. Black
Senior Vice President & Chief Financial Officer
Dr. David A. King Ph.D.
Senior Vice President of Global R&D
Dr. Michael Egholm Ph.D.
Pres, Chief Executive Officer & Director
Mr. Hanjoon Kim
Chief Operating Officer
Ms. Agnieszka M. Gallagher J.D.
Senior Vice President & Chief Legal Officer
Steve Kulisch
Senior Vice President, GM & Head of Strategic Marketing
Mr. Vikram Jog
Chief Financial Officer
Mr. Stephen Christopher Linthwaite
Advisor
Ms. Angela Peters
Chief HR Officer
Mr. Rafael Aguirre-Sacasa
Acting Gen. Counsel
Ms. Mona Abou-Sayed
Senior Vice President of SBS
Mr. Peter DeNardo
Senior Director of Investor Relations & Corporation Communications
LAB's closing price is 56.2% higher than its 52-week low of $1.21 where as its distance from 52-week high of $3.04 is -37.83%.
Number of LAB employees currently stands at 534.
Official Website of LAB is: https://www.fluidigm.com
LAB could be contacted at phone 650 266 6000 and can also be accessed through its website. LAB operates from 2 Tower Place, South San Francisco, CA 94080, United States.
LAB stock volume for the day was 102.58K shares. The average number of LAB shares traded daily for last 3 months was 2.2M.
The market value of LAB currently stands at $698.66M with its latest stock price at $1.88 and 371.15M of its shares outstanding.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com